No Data
ADRs Close Higher; Phoenix New Media Ltd. Cl A Climbs 38%
BioLineRx Stock Jumps 14% on St. Jude Clinical Trial for Mitoxafortide
Express News | BioLineRx Announces Multi-Center Phase 1 Trial Sponsored By St. Jude Children's Research Hospital To Evaluate Motixafortide For CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications In Sickle Cell Disease
Earnings Call Summary | BioLine Rx(BLRX.US) Q1 2024 Earnings Conference
BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript
Express News | BioLineRx Shares Are Trading Higher. The Company Reported Q1 Financial Results
No Data
Sean Parker : let's hope it goes up when the market opens. doesn't seem like people are interested yet
.
Trytosaveabit OP Sean Parker : True! Hard to say if they will like it? GL
Sean Parker Trytosaveabit OP : I feel like it's good news all around. plus with a 21PT I'm not sure how .7 doesn't seem like a good buy. I know I sold what I could and bought in.
Trytosaveabit OP Sean Parker : Right! Can’t say that I disagree with your assessment! Hehehe